ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Ferroptosis: From Basic Research to Clinical Therapeutics in Hepatocellular Carcinoma

Huang, Ziyue; Xia, Haoming; Cui, Yunfu; Yam, Judy Wai Ping*; Xu, Yi*哈尔滨医科大学; y
Journal of Clinical and Translational Hepatology2023-1DOI: 10.14218/JCTH.2022.00255
10被引8阅读
引用收藏
分享

摘要

Hepatocellular carcinoma (HCC) is one of the most common and highly heterogeneous malignancies worldwide. Despite the rapid development of multidisciplinary treatment and personalized precision medicine strategies, the overall survival of HCC patients remains poor. The limited survival benefit may be attributed to difficulty in early diagnosis, the high recurrence rate and high tumor heterogeneity. Ferroptosis, a novel mode of cell death driven by iron-dependent lipid peroxidation, has been implicated in the development and therapeutic response of various tumors, including HCC. In this review, we discuss the regulatory network of ferroptosis, describe the crosstalk between ferroptosis and HCC-related signaling pathways, and elucidate the potential role of ferroptosis in various treatment modalities for HCC, such as systemic therapy, radiotherapy, immunotherapy, interventional therapy and nanotherapy, and applications in the diagnosis and prognosis of HCC, to provide a theoretical basis for the diagnosis and treatment of HCC to effectively improve the survival of HCC patients.

学科与关键词

关键词
Hepatocellular carcinomaFerroptosisSorafenibCancer therapyMolecular targets
相关
加载中…
  • Ferroptosis: The Silver Lining of Cancer Therapy
    Tang, Zhengming; Huang, Zhijie; Huang, Yisheng; Chen, Yuanxin; Huang, Mingshu; Liu, Hongyu; Ye, Q. Adam*; Zhao, Jianjiang*; Jia, Bo*Frontiers in Cell and Developmental Biology, 2021, 9: 765859.被引 27
  • Development and validation of four ferroptosis-related gene signatures and their correlations with immune implication in hepatocellular carcinoma
    Zhang, Ying; Ren, He; Zhang, Chunting; Li, Haihua; Guo, Qingzhi; Xu, Haitao*; Cui, Lina*Frontiers in Immunology, 2022, 13: 1028054.被引 10
  • Ferroptosis-Based Therapeutic Strategies toward Precision Medicine for Cancer
    Shi, Tong-Mei; Chen, Xiao-Fei*; Ti, Huihui*Journal of Medicinal Chemistry, 2024, 67(4): 2238-2263.
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Clinical and Translational Hepatology
发表日期
2023-01
卷期
第 11 卷, 第 1 期
页码
207-218
DOI
10.14218/JCTH.2022.00255
成果收录
SCIE
资助标注
Hong Kong Scholars Program [XJ2020012]; National Natural Science Foundation of China [81902431]; Excellent Youth Project of Natural Science Foundation of Heilongjiang [YQ2019H007]; Special Project of China Postdoctoral Science Foundation [2019T120279]; Special Project of Heilongjiang Postdoctoral Science Foundation [LBH-TZ1016]; China Postdoctoral Science Foundation [2018M641849, 2018M640311]; Heilongjiang Postdoctoral Science Foundation [LBH-Z18107, LBH-Z18112]; Fundamental Research Funds for the Heilongjiang Provincial Universities [2018-KYYWF-0511, 2018-KYYWF-0498]; Postgraduate Innovative Research Project of Harbin Medical University [YJSCX2016-21HYD]; Foundation of Key Laboratory of Myocardial Ischemia, Ministry of Education [KF201810]; Chen Xiaoping Foundation for the Development of Science and Technology of Hubei Province [CXPJJH11800004-001, CXPJJH11800004-003]

作者

  • H

    Huang, Ziyue (第一作者)

    2 · harbin med univ

  • X

    Xia, Haoming

    2 · harbin med univ

查看全部 5 位作者收起作者
  • C

    Cui, Yunfu

    2 · harbin med univ

  • Y

    Yam, Judy Wai Ping (通讯)

    univ hong kong

  • X

    Xu, Yi (通讯)

    harbin med univ · univ hong kong · 2

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417